Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.1619
-0.1120 (-40.89%)
Oct 10, 2025, 11:19 AM EDT - Market open
Carisma Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Cash & Equivalents | 2 | 17.91 | 77.61 | 24.19 | 162.64 | 52.39 | Upgrade |
Short-Term Investments | - | - | - | 27.8 | - | - | Upgrade |
Cash & Short-Term Investments | 2 | 17.91 | 77.61 | 52 | 162.64 | 52.39 | Upgrade |
Cash Growth | -95.05% | -76.92% | 49.25% | -68.03% | 210.44% | 8.87% | Upgrade |
Accounts Receivable | - | - | - | - | 21.01 | - | Upgrade |
Other Receivables | - | - | - | - | 3.48 | - | Upgrade |
Total Trade Receivables | - | - | - | - | 24.49 | - | Upgrade |
Other Current Assets | 2.3 | 5.92 | 2.87 | 2.6 | 18.5 | 10.5 | Upgrade |
Total Current Assets | 4.3 | 23.83 | 80.47 | 54.59 | 205.61 | 62.87 | Upgrade |
Net Property, Plant & Equipment | 0.72 | 6.43 | 8.94 | 13.45 | 0.04 | 0.12 | Upgrade |
Other Intangible Assets | - | - | - | - | 14.7 | 46.4 | Upgrade |
Goodwill | - | - | - | - | 13.06 | 13.06 | Upgrade |
Other Long-Term Assets | - | 0.21 | 0.15 | 4.11 | 7.32 | 0.35 | Upgrade |
Total Assets | 5.01 | 30.46 | 89.55 | 72.15 | 240.75 | 122.82 | Upgrade |
Accounts Payable | 4.76 | 2.08 | 3.93 | 1.73 | 2.85 | 3.1 | Upgrade |
Accrued Expenses | 2.53 | 7.45 | 7.66 | 10.36 | 8.26 | 3.97 | Upgrade |
Short-Term Debt | - | - | - | 33.72 | - | - | Upgrade |
Current Portion of Leases | 1.05 | 1.74 | 1.94 | 4.6 | - | - | Upgrade |
Unearned Revenue | 41.25 | 44.98 | 46.41 | 47.46 | 1.5 | 3 | Upgrade |
Other Current Liabilities | 0.61 | 1.06 | 0.97 | 6.26 | 0.46 | 9.47 | Upgrade |
Total Current Liabilities | 8.95 | 16.06 | 15.91 | 19.67 | 11.57 | 18.05 | Upgrade |
Long-Term Leases | 0.65 | 0.74 | 1.19 | 1.85 | - | - | Upgrade |
Other Long-Term Liabilities | 0.17 | 0.32 | 0.93 | 1.04 | 55.97 | 112.5 | Upgrade |
Total Long-Term Liabilities | 0.82 | 1.06 | 2.11 | 2.89 | 57.47 | 114 | Upgrade |
Total Liabilities | 51.02 | 58.37 | 63.02 | 107.02 | 69.04 | 132.05 | Upgrade |
Preferred Stock | - | - | - | 107.81 | - | - | Upgrade |
Common Stock | 0.04 | 0.04 | 0.04 | 0 | 0.2 | 0.14 | Upgrade |
Additional Paid-in Capital | 278.57 | 277.63 | 271.59 | 1.2 | 487.77 | 306.55 | Upgrade |
Accumulated Other Comprehensive Income | - | - | - | -0.04 | - | - | Upgrade |
Retained Earnings | -324.62 | -305.58 | -245.1 | -158.22 | -316.26 | -315.92 | Upgrade |
Total Common Shareholders' Equity | -46.01 | -27.91 | 26.53 | -49.26 | 171.71 | -9.23 | Upgrade |
Minority Interest | - | - | - | 14.4 | - | - | Upgrade |
Shareholders' Equity | -46.01 | -27.91 | 26.53 | -142.67 | 171.71 | -9.23 | Upgrade |
Total Liabilities & Equity | 5.01 | 30.46 | 89.55 | 72.15 | 240.75 | 122.82 | Upgrade |
Total Debt | 1.7 | 2.48 | 3.12 | 40.16 | 0 | 0 | Upgrade |
Net Cash (Debt) | 0.3 | 15.43 | 74.48 | 11.83 | 162.64 | 52.39 | Upgrade |
Net Cash Growth | -98.06% | -79.29% | 529.50% | -92.73% | 210.44% | 8.87% | Upgrade |
Net Cash Per Share | 0.01 | 0.37 | 2.22 | 5.56 | 17.84 | 8.86 | Upgrade |
Book Value | -46.01 | -27.91 | 26.53 | -49.26 | 171.71 | -9.23 | Upgrade |
Book Value Per Share | -1.10 | -0.67 | 0.79 | -23.15 | 18.84 | -1.56 | Upgrade |
Tangible Book Value | -46.01 | -27.91 | 26.53 | -49.26 | 143.95 | -68.69 | Upgrade |
Tangible Book Value Per Share | -1.10 | -0.67 | 0.79 | -23.15 | 15.79 | -11.62 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.